Hostility, age, and mortality in a sample of cardiac patients

Stephen H Boyle1, Redford B Williams, Daniel B Mark

  • 1Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina, USA. shboyle@duke.edu

Insights

Hostility predicts survival in coronary artery disease patients. This association was significant only in younger patients, indicating age modifies the impact of hostility on cardiac patient survival.

Area of Science:

  • Cardiology
  • Psychosomatic Medicine
  • Health Psychology

Background:

  • Coronary artery disease (CAD) poses a significant health burden.
  • Psychological factors, such as hostility, are increasingly recognized as potential contributors to cardiovascular outcomes.
  • Understanding predictors of survival in CAD patients is crucial for clinical management.

Purpose of the Study:

  • To investigate hostility as a predictor of survival in patients with documented coronary artery disease.
  • To determine if age modifies the relationship between hostility and survival in this patient group.

Main Methods:

  • A cohort of 1,328 patients with documented coronary artery disease was studied.
  • Hostility was assessed as a predictor variable.
  • Survival data was analyzed, controlling for disease severity and age.

Main Results:

  • A significant interaction between age and hostility was observed.
  • Hostility was significantly associated with poorer survival.
  • This association was evident specifically in younger patients (age <61.2 years).

Conclusions:

  • Hostility is a significant predictor of poorer survival in younger patients with coronary artery disease.
  • Age is a critical factor modulating the impact of hostility on survival in CAD.
  • Clinical assessment of hostility may be particularly relevant for younger CAD patients.

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...